Myocardial infarction (MI) results in acute impairment of left ventricular (LV) function through the initial development of cardiomyocyte death and subsequent progression of LV remodelling. The expression of syndecan-4 (Sdc4), a transmembrane proteoglycan, is up-regulated after MI, but its function in the heart remains unknown. Here, we characterize the effects of Sdc4 deficiency in murine myocardial ischaemia and permanent infarction.
Introduction
Myocardial infarction (MI) remains the most frequent cardiovascular condition and can-beyond its immediate lethality-lead to cardiac failure and its associated late lethality. Cardiac failure is determined by the amount of myocardial tissue lost during ischaemia and, if reperfusion is achieved, the ensuing reperfusion injury, as well as by subsequent ventricular remodelling that adversely affects ventricular geometry.
Ischaemic myocardial damage depends on cardiomyocyte apoptosis and necrosis. 1 Reperfusion injury is due to leucocyte-mediated cardiomyocyte bystander death during removal of necrosis. Growth of the defect also occurs secondary to stretch-induced tissue loss called non-ischaemic infarct expansion. 2, 3 Infarct healing can be divided into an early inflammatory and a late post-inflammatory phase. 4 The early inflammatory phase entails invasion of the infarcted tissue by leucocytes and removal of necrosis, population of the infarcted tissue by myofibroblasts and macrophages, and replacement of † These authors contributed equally to this work.
necrosis by granulation tissue. The cellular events during this process in principle resemble wound healing in other tissues. 5 However, haemodynamic strain and the release of pro-hypertrophic growth factors in the myocardium during healing are responsible for an additional phenomenon: adverse remodelling that determines longterm functional outcome after infarction. 6 Syndecans are a family of transmembrane heparansulfate proteoglycans that regulate cell -cell and cell -matrix interactions. 7 Increased levels of syndecan-4 (Sdc4) were detected in the plasma of MI patients. 8 Expression of syndecan-1 (Sdc1) and Sdc4 is increased in the infarcted and the remote myocardium in animal models of MI. 9 Sdc1, which is mainly expressed in inflammatory and vascular cells, has recently been shown to affect ischaemic myocardial damage by reducing inflammation and thereby left ventricular (LV) dilatation after ischaemia. 10 Sdc4 is located within costamers and the Z-disc of cardiomyocytes, 11 which are thought to be important sites for mechano-sensing in cardiomyocytes. 12 Sdc4 has been shown to translate mechanical stretch into cytoplasmic signalling in fibroblasts. 13 Wound healing in the skin is disturbed and delayed in Sdc4-deficient mice, 14 but the role of Sdc4 for myocardial wound healing and early remodelling has not been elucidated. We therefore examined the effects of Sdc4 deficiency on myocardial damage and early infarct healing in mouse models of myocardial ischaemia and infarction.
Methods

Transgenic mice and models of MI and myocardial ischaemia with reperfusion injury
This study was approved by the Institutional Review Board and performed in accordance with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health. Sdc4 -/ -mice were backcrossed for more than 10 generations on C57BL/6 mice and ageand sex-matched Sdc4 -/ -and Sdc4 +/+ [wild-type (WT)] offspring of heterozygous matings were used for all studies. For myocardial ischaemia with reperfusion (MI/R) injury, the left coronary artery (LAD) was ligated for 30 min followed by 24 h of reperfusion. Area at risk (AAR) and infarct size were determined by TTC/Coomassie staining as described. 15 Data are presented as the average per cent infarct size per AAR. MI was induced by permanent ligation of the LAD as published previously. 16 Hearts were taken out 7 days later for molecular and histological analyses. Blood was collected from the retrobulbar plexus 24 h after MI or was drawn from the inferior vena cava before mice were sacrificed. Plasma was separated and troponin T levels were assessed by using Elecsys Troponin T high-sensitive test (Roche Diagnostics, Mannheim, Germany). 17 
Cell culture
Primary neonatal rat ventricular cardiomyocytes were harvested from 1-to 3-day-old Sprague-Dawley rat pups (Charles River, Sulzfeld, Germany) as published elsewhere. 18 Cardiomyocytes were transfected with siRNA to Sdc4 (151941, Applied Biosystems, Darmstadt, Germany) or nonspecific (scr)-siRNA (1027281, Qiagen, Hilden, Germany) using RNAiMAX (Invitrogen, Karlsruhe, Germany). Twenty-four hours later, cells were stimulated with phenylephrine (PE) or exposed to 0.8% O 2 (hypoxia) for 3 h and reoxygenated in room air (21% O 2 ) for 1 h.
Real-time RT-PCR
Total RNA was extracted from the non-ischaemic and ischaemic myocardium and from rat cardiomyocytes using TRItidy reagent (Applichem, Darmstadt, Germany). Reagents and primers were purchased from Eurogentec (Cologne, Germany). Samples were run in duplicates on a realtime PCR cycler (Rotogene 3000, Corbett Life Science, Hilden, Germany). Signals were generated by MESA-GREEN incorporation into the amplified DNA, normalized to HPRT or GAPDH gene expression and expressed as 2 2D(DCT) .
Immunohistochemistry
Hearts were perfusion-fixed (4% paraformaldehyde), harvested from animals, and paraffin-embedded. 
Hypertrophy assessment
For calculation of cell surface area in vitro, siRNA-transfected rat cardiomyocytes were stimulated with PE (Sigma-Aldrich, Munich, Germany) at a final concentration of 10 mM for 24 h. Surface area was determined with ImageJ 10.2 analysis software (NIH). Cells from 10 randomly selected fields in three independent experiments were examined and the surface area was compared with scr-siRNA-treated cells (300 cells each).
NFAT activity assay
AdNFAT-luc was used to infect neonatal rat cardiomyocytes that were additionally transfected with either scr-or Sdc4-siRNA for 24 h before PE was added for 24 h. The cells were then collected to determine luciferase activity as described previously. 19 One hundred per cent of the myocytes were infected with the luciferase reporter such that luciferase activity was normalized to total protein. 20 
Echocardiographic measurements
Mice were anaesthetized with isoflurane (1.5vol% in air). The chest was shaved and 2D-guided M-mode echocardiography was performed (HP-Sonos 5500, Hewlett Packard, Palo Alto, CA, USA) using a 12 MHz probe to derive LV functional and dimensional parameters. Long-and short-axis views were obtained as described elsewhere.
16,21
Statistical analysis
Data are presented as mean + SEM. Whenever data displayed nonGaussian distributions or significantly different SDs, the Kruskal-Wallis test followed by the Mann-Whitney U test, otherwise ANOVA followed by t-test was performed (Prism, GraphPad Inc., San Diego, CA, USA). In experiments with multiple comparisons of multiple groups, Dunnett's test was applied following analysis of variances. All authors had full access to the data and take full responsibility for their integrity. All authors have read and agree to the manuscript as written.
Results
Sdc4 reduces ischaemiareperfusion-induced myocardial damage
Sdc4 is expressed in the costameric region of cardiomyocytes. 11 Its role for cardiac function and disease needs yet to be investigated. We analysed Sdc4 -/ -mice for susceptibility to ischaemia-reperfusion injury. Sdc4 -/ -and WT mice were subjected to MI/R. In WT mice, LV cross-sectional area was 10.6 + 0.6 mm 2 . Ligation of the LAD resulted in an ischaemic area of 6.2 + 0.3 mm 2 (n ¼ 7) constituting the AAR. The infarct area was 2.9 + 0.2 mm 2 (n ¼ 7). Neither LV area nor AAR was statistically different between treatment groups. Loss of viable myocardium was increased by 40% in Sdc4 -/ -compared with WT mice ( Figure 1A ). 24 h after ischaemia, plasma troponin T was 1.6-fold elevated in Sdc4 -/ -compared with WT mice (P , 0.01; Figure 1B ). This increase in myocardial damage was associated with enhanced apoptosis in Sdc4 -/ -mice since cleaved caspase-3 (clCasp3) was increased in Sdc4 -/ -compared with WT infarcts ( Figure 1C and D).
To assure that apoptosis actually occurs in cardiomyocytes and depends on Sdc4, we used siRNA in primary rat neonatal cardiomyocytes that reduced Sdc4 levels to 25%. Three hours of hypoxia with 1 h reoxygenation significantly increased the number of TUNELpositive cardiomyocytes in Sdc4-siRNA-treated cells compared with cells treated with non-specific (scr)-siRNA ( Figure 1G) . We have previously shown that Sdc4 signals in part through the mitogen-activated protein kinase ERK. 22 In MI/R, ERK dephosphorylation enhances apoptosis during reperfusion. 23 Phosphorylation of p44-ERK was reduced after ischaemic -reperfusion injury in Sdc4
-/ -hearts compared with sham animals ( Figure 1E and F ). Although p38 MAPK is activated in ischaemic hearts, no difference in the ratio of phosphorylated to total p38 was detected between Sdc4 -/ -and WT hearts (34.2 + 17.9-vs. 36.6 + 14.4-fold increase in p-p38/p38 sham, Sdc4 -/ -vs. WT, n ¼ 5, NS) ( Figure 1E ). Sdc4 knockdown reduced p44-ERK-phosphorylation in vitro in ischaemic cardiomyocytes to 73% of WT p44-ERK phosphorylation, suggesting that Sdc4 prevents myocardial damage by reducing apoptosis of cardiomyocytes through p44-ERK activation ( Figure 1H and I ).
Increased cardiomyocyte size in the border zone of MI/R mice
Since Sdc4 -/ -animals display disturbed early healing when suffering skin wounds, 14 we morphometrically analysed the infarct, the border zone, and the remote myocardium. Figure 1 Loss of Sdc4 enhances myocardial damage after ischaemic -reperfusion injury (MI/R). After 30 min of ischaemia followed by 24 h of reperfusion, myocardial damage was less pronounced in WT than Sdc4 -/ -mice as represented by infarct size (A) and plasma troponin T (B). Apoptosis was increased in ischaemic Sdc4 -/ -hearts compared with WT and control (sham) as assessed by immunoblotting of clCasp3 (C and D). Phosphorylated ERK1/2 (pERK) and the ratio to total ERK1/2 (E and F) were decreased in the absence of Sdc4, whereas p38 phosphorylation was induced by ischaemia but unaffected by Sdc4. In vitro was the anti-apoptotic effect of Sdc4 in cardiomyocytes demonstrated by Scd4-siRNA knockdown that had been subjected to 3 h hypoxia with 1 h reoxygenation by TUNEL (G) and immunoblotting of pERK (H and I).
Typical blots are shown in (C), (E), and (H). Data from n ¼ 4-8 experiments are presented in (A -C), (E), (G), and (H).
Syndecan-4 regulates ERK and NFAT activity in MI/R and MI the border zone revealed that 24 h after MI/R, cardiomyocytes in the AAR of WT and Sdc4 -/ -mice were enlarged compared with the remote myocardium. Cardiomyocyte enlargement was significantly enhanced in Sdc4 -/ -compared with WT mice (Figure 2A and B).
To examine whether cardiomyocyte enlargement was changed due to effects of Sdc4 on reoxygenation/reperfusion injury, we examined in vitro if Sdc4 affects cardiomyocyte size in a model for hypoxia and reoxygenation. Hypoxia and reoxygenation did not induce enlargement of cardiomyocytes, regardless of the presence of Sdc4 (data not shown). We therefore reasoned that increased mechanical strain could-by virtue of the sudden loss of 30% of the LV muscle mass-represent an adequate stimulus for the onset of a hypertrophic remodelling process in the border zone. Stimulation of rat cardiomyocytes with PE was used as an in vitro model for workload-induced hypertrophy. Cardiomyocyte growth was enhanced by 15% in Sdc4-siRNA-treated cells compared with controls (scr-siRNA) during PE stimulation ( Figure 2C ). Sdc4 knockdown compared with scr-siRNA also significantly increased atrial natriuretic peptide (ANP) expression in PE-stimulated cardiomyocytes as a marker for hypertrophy ( Figure 2D ). F ). In addition, Sdc4 deficiency increased cardiomyocyte area in the infarct border zone compared with WT hearts (Figure 2E and F ) . In contrast to MI/R, we also detected an increase in cardiomyocyte area of Sdc4 -/ -MI hearts in the remote myocardium compared with WT mice, indicating that MI did cause more strain and thereby remodelling, leading to an increased hypertrophic response in the remote myocardium. We conclude that loss of myocardial mass induces an early hypertrophic response in the non-infarcted myocardium which is augmented in Sdc4-deficient animals.
3. 4 Enhanced NFAT activation in non-infarcted myocardium of Sdc4 -/ -mice
We further asked whether known molecular drivers of workload-induced hypertrophy would be activated in myocardial ischaemia models and if Sdc4 alters their activity. Therefore, we examined NFAT activity in the border zone and the remote myocardium of MI/R hearts. Activation of NFAT is characterized by its dephosphorylation through the phosphatase calcineurin and translocation of NFAT from the cytoplasm into the nucleus. 25 Twenty-four hours after MI/R, we detected low frequencies of NFAT-positive nuclei in the border zone ( 4%) of WT mice and none in the remote myocardium. The frequency of NFAT-positive cardiomyocytes was slightly but significantly increased (6%) in the border zone of Sdc4 -/ -mice ( Figure 3A and B). To assure that NFAT activation induced transcriptional programmes at this low level of activity, we assessed expression of a downstream NFAT target. Compared with sham, exon 4 splice isoform of the regulator of calcineurin 1 (rcan1.4) 26,27 was 1.4-fold induced in the WT border zone after MI/R (n ¼ 8, P , 0.05). In Sdc4 -/ -infarcts, we observed a 1.9-fold non-significant trend for an elevation of rcan1.4-RNA compared with sham (P ¼ 0.07 vs. WT; Figure 3C ). No increase in rcan1.4 expression was detected in the remote myocardium of both WT and Sdc4 -/ -hearts following MI/ R compared with sham ( Figure 3C ). Seven days after permanent infarction, the frequency of NFAT-positive nuclei in the border zone was between 15 and 40%, thus about 10-fold higher compared with the border zone after transient ischaemia. We detected 1.5-fold more NFAT-positive nuclei in the infarct border of Sdc4 -/ -than in WT mice ( Figure 3D and E). Enhanced NFAT activity was confirmed by a 2.2-fold increase in rcan1.4 expression in the infarct area and NFAT activity in the remote myocardium induced a two-fold increase in rcan1.4 expression in the remote myocardium of Sdc4 -/ -vs.
WT-MI hearts ( Figure 3F ).
Our data indicate that MI induces enhanced hypertrophic remodelling in Sdc4
-/ -mice through increased NFAT activation.
Sdc4 regulates NFAT activity induced by adrenergic strain in vitro
We then asked whether Sdc4-mediated NFAT activation and rcan1.4 transcription in cardiomyocytes is secondary to oxygen deprivation or strain. To this end, we analysed the influence of Sdc4 on NFAT activity in PE-stimulated or hypoxic and reoxygenated neonatal rat cardiomyocytes. NFAT activity in cardiomyocytes was determined using a NFAT luciferase reporter system. 19 To test whether NFAT activity in the AAR was induced by hypoxia, we subjected cardiomyocytes transduced with the NFAT reporter to hypoxia and reoxygenation. Hypoxia did not activate NFAT in cardiomyocytes. Sdc4 knockdown did not induce NFAT activity ( Figure 4A) . PE stimulation induced an approximately three-fold increase in NFAT activity in cells transduced with scr-siRNA, whereas Sdc4-siRNA-treated cardiomyocytes demonstrated a 10-fold increase in NFAT activity upon PE stimulation ( Figure 4B ).
Sdc4 affects infarct healing
Morphological characterization early on after MI revealed no differences in leucocyte recruitment and capillary density. After 14 days of MI, granulation tissue is almost completely removed by phagocytosis of granulocytes in WT infarcts. Although similar numbers of neutrophil granulocytes were recruited to WT and Sdc4 -/ -infarcts, a reduced clearance of granulation tissue was noted in Sdc4 -/ -mice accompanied by reduced collagen deposition. However, the numbers of aSMA-positive myofibroblasts that are responsible for granulation tissue synthesis and the numbers of newly formed capillaries were not different between WT and Sdc4 -/ -mice ( Figure 5 and Table 1 ).
Sdc4 improves remodelling and functional recovery after MI
To assess whether Sdc4 deficiency had functional consequences on myocardial geometry and function after MI echocardiography was carried out. In the absence of baseline differences, typical changes of LV function and ventricular wall thicknesses occurred in both groups, while no differences between WT and Sdc4 -/ -animals were noted. LV geometry was however significantly different demonstrating accentuated dilatation as evidenced by a less increase in enddiastolic and end-systolic volumes in Sdc4 -/ -hearts 7 days after permanent infarction compared with baseline ( Figure 6A and B) . Geometric advantages ( Figure 6C ) translated into an improved ejection fraction in Sdc4 -/ -compared with WT-MI hearts whereas cardiac output did not change ( Figure 6D ).
Discussion
Here, we present data supporting a dual role for Sdc4 during myocardial ischaemia and early healing of ischaemia-induced tissue defects pertaining to anti-apoptotic as well as anti-hypertrophic effects that ultimately add up to a beneficial effect of the global Sdc4 absence on LV remodelling and function. These findings point to Sdc4 as an important molecule to study the biology of infarct healing and in light of available Sdc4-blocking antibodies as an attractive target to treat human myocardial ischaemia and remodelling. In a model of transient ischaemia with reperfusion, we show that Sdc4 prevents myocardial damage by reducing cardiomyocyte apoptosis during infarct expansion resulting in larger defects in Sdc4 -/ -mice. Myocardial damage after post-ischaemic reperfusion injury depends on cardiomyocyte apoptosis and necrosis, 1 associated with increased activity of the apoptosis-specific effector caspase-3. 28 We detected further increased caspase-3 activity in reperfused postischaemic myocardium of Sdc4 -/ -mice, indicating that myocardial damage is associated with enhanced apoptosis. In vitro, Sdc4 has been attributed to have pro-and anti-apoptotic effects that depend on cell type and engaged ligands that are examined. 29, 30 We and others had identified ERK activation as one prominent Sdc4 signalling pathway in mesenchymal cells triggered by pro-inflammatory cytokines, 13, 22, 31 suggesting that in cardiomyocytes of the inflamed myocardium, the ERK pathway might also be affected by Sdc4 deficiency. 23 , 32 We show here that phosphorylation of p44-ERK is Syndecan-4 regulates ERK and NFAT activity in MI/R and MI reduced in Sdc4-deficient myocardium 24 h after MI/R and in hypoxic cardiomyocytes.
In the post-ischaemic myocardium of Sdc4 -/ -animals, we observed increased cardiomyocyte dimensions pointing to an additional role of Sdc4 in regulating the onset of hypertrophic responses in non-infarcted tissue, a phenomena that has been described in the framework of late reperfusion effects on ventricular geometry in humans and rodents, but the underlying mechanisms are ill-defined. 2,3,33 -35 The hypertrophic response of cardiomyocytes to pressure overload or MI with heart failure induces activation of NFAT. 25, 26, 36 NFAT activation is induced by intracellular Ca 2+ -and calcineurin-dependent NFAT dephosphorylation. It induces nuclear NFAT translocation and transcription of its target rcan1.4. 31 We demonstrate here for the first time activation of the NFAT pathway in the AAR as early as 24 h after transient ischaemia with more cells displaying nuclear NFAT staining and increased transcriptional levels of rcan1.4 expression. However, in ischaemic-reperfusion injury, Sdc4 has only mild effects on NFAT activation and rcan1.4 expression in vivo and Sdc4 is not modulating NFAT activity in hypoxic cardiomyocytes in vitro.
To approach strain-induced post-infarct remodelling in vivo, we assessed the influence of Sdc4 on infarct healing and remodelling in the permanent ligation model.
The role of Sdc4 during early infarct healing is not known at present and the prediction of Sdc4's role in this process is difficult, since the function of Sdc4 is tissue-, cell-and stimulus-dependent. 7 In skin wound healing, Sdc4 expression is up-regulated in fibroblasts at the wound edges and Sdc4 -/ -mice exhibit reduced synthesis of granulation tissue and lack of wound contraction.
14 In contrast to skin wounds, myocardial infarcts develop during hours and face the stress of rhythmic cardiac contractions, 37 leading to different Sdc4-dependent changes in wound healing. In permanent MIs, the loss of Sdc4 leads to a delay in removal of granulation tissue in the face of similar early inflammatory cell recruitment. If this defect depends on diminished phagocytosis of granulocytic infiltrates or on Syndecan-4 regulates ERK and NFAT activity in MI/R and MI infarct expansion of the weaker collagen core of the infarct needs to be analysed in more detail. Ventricular aneurysms did not develop and infarct sizes at 7 days were not different in Sdc4-knockout compared with WT. We did however observe accentuated hypertrophic remodelling in the infarct border zone and the remote myocardium most likely in response to mechanical strain. Whereas 21 days after permanent infarction NFAT activity had previously been reported, 36 we demonstrate 7 days post-MI that the number of cells displaying nuclear NFAT translocation in WT mice was 10-fold increased in the border zone compared with transient ischaemia and was also robustly induced in the remote myocardium. In MI, loss of Sdc4 further enhanced NFAT translocation and transcriptional induction of the NFAT target rcan1.4 in the non-infarcted myocardium. Strain-dependent NFAT activity was detected during PE stimulation but not during hypoxia in vitro. Sdc4 knockdown further increased NFAT activation 10-fold if cells experienced PE stimulation. In numerous reports, activation of the calcineurin -NFAT pathway has been observed in pathological hypertrophy and failing hearts after MI, but newer data challenge this view as calcineurin might in addition control physiological myocyte growth and cardiac angiogenesis. 38 In our study, loss of Sdc4 induces NFAT activation and rcan1.4 transcription very early on. In fact, we observe an increase in cardiomyocyte area as briefly as 24 h after transient ischaemia. Although we are able to demonstrate that NFAT pathway activation has taken place to some extent at this time, it seems unlikely that actual hypertrophy can have occurred at this time. We therefore attribute the increased cardiomyocyte area rather to swelling due to myocardial stunning then to actual increase in cell material. At later stages of early infarct healing, hypertrophy is however occurring. Sdc4 by interacting with the calcineurin pathway may therefore uncouple cardiac hypertrophy from adverse remodelling and render hypertrophic responses in the non-infarcted tissue beneficial. We conclude that hypertrophic remodelling is induced by enhanced wall strain in cardiomyocytes during early infarct healing and that Sdc4 deficiency further enhanced NFAT-dependent hypertrophic cardiomyocyte remodelling which resulted in improved LV geometry and function. The molecular mechanisms leading to NFAT activation by Sdc4 remain elusive. It is known that protein kinase C activation requires binding of phosphoinositol-4,5-biphosphate (PIP 2 ) to the cytoplasmic domain of Sdc4. 39 Enhanced NFAT activation in Sdc4 -/ -cardiomyocytes may thus be due to increased levels of PIP 2 that is otherwise bound and scavenged by Sdc4. Unbound PIP 2 can be hydrolysed by phospholipase Cg to inositol 1,4,5-triphosphate (IP3). IP3 signals Ca 2+ transients, which induce calcineurin-dependent NFAT activation. In addition, Sdc4 binds to a-actinin in fibroblasts and one might speculate that at the Z-discs of myocytes, this interaction will bring Sdc4 into close proximity to calcineurin. This may target calcineurin to the necessary subcellular location to undergo Ca 2+ -dependent activation similarly to the recently reported CIB1, 20 although in contrast to the latter, Sdc4 appears to have an inhibitory role on calcineurin/NFAT signalling, similar to what was reported for the calsarcins. 40 Our study is limited by the fact that we cannot rule out that the beneficial effect of Sdc4 deficiency in the early phase of infarct healing maybe consumed over time by the net increase in myocardial tissue loss. Conclusive long-term studies on functional consequences of Sdc4 deficiency during myocardial stress responses are needed. Also, we cannot rule out that the involvement of Sdc4 in myocardial remodelling processes through calcineurin activation requires binding to an extracellular ligand nor that it does require direct intracellular interaction with the signalling molecules calcineurin or NFAT themselves. Finally, for therapeutic approaches, we have proved the principle of blocking Sdc4 by antibody application in a mouse osteoarthritis model. 22 During myocardial healing, however, the timing for Sdc4 pathway interception needs to be further elucidated to explore the potential to separate the beneficial effects of Sdc4 inhibition on remodelling from the adverse effects of cardiomyocyte apoptosis.
We have shown that Sdc4-dependent regulation of the MAPK ERK has profound effects on cardiomyocyte survival in MI. In addition, we demonstrate that calcineurin/NFAT intercepting or enhancing interventions may allow for steering of myocardial healing processes potentially through Sdc4.
